PA8568901A1 - Nuevos derivados de azepano - Google Patents

Nuevos derivados de azepano

Info

Publication number
PA8568901A1
PA8568901A1 PA20038568901A PA8568901A PA8568901A1 PA 8568901 A1 PA8568901 A1 PA 8568901A1 PA 20038568901 A PA20038568901 A PA 20038568901A PA 8568901 A PA8568901 A PA 8568901A PA 8568901 A1 PA8568901 A1 PA 8568901A1
Authority
PA
Panama
Prior art keywords
azepano
new derivatives
plasma
stability
development
Prior art date
Application number
PA20038568901A
Other languages
English (en)
Inventor
Walter-Gunar Friebe
Birgit Masjost
Ralf Schumacher
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of PA8568901A1 publication Critical patent/PA8568901A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/02—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D223/06—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D223/12—Nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

LA INVENCION PROPORCIONA NUEVOS DERIVADOS DE AZEPANO O SALES FARMACEUTICAMENTE ACEPTABLES DE LOS MISMOS, DE ACUERDO CON LA FORMULA (I) EN DONDE LOS SIMBOLOS RESTANTES TIENEN EL SIGNIFICADO DADO EN LA ESPECIFICACION, ASI COMO LOS PROCESOS PARA SU ELABORACION. LOS COMPUESTOS DE ACUERDO A ESTA INVENCION POSEEN ACTIVIDAD DE ANTI-PROLIFERACION CELULAR Y MUESTRAN UN AUMENTO DE LA ESTABILIDAD EN PLASMA.
PA20038568901A 2002-03-12 2003-03-11 Nuevos derivados de azepano PA8568901A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02005287 2002-03-12
EP02006648 2002-03-26

Publications (1)

Publication Number Publication Date
PA8568901A1 true PA8568901A1 (es) 2003-12-10

Family

ID=27806513

Family Applications (1)

Application Number Title Priority Date Filing Date
PA20038568901A PA8568901A1 (es) 2002-03-12 2003-03-11 Nuevos derivados de azepano

Country Status (12)

Country Link
US (1) US6887864B2 (es)
EP (1) EP1487819A2 (es)
JP (1) JP2005524671A (es)
CN (1) CN1321116C (es)
AR (1) AR038916A1 (es)
AU (1) AU2003218715A1 (es)
CA (1) CA2478276A1 (es)
PA (1) PA8568901A1 (es)
PE (1) PE20040205A1 (es)
TW (1) TW200401644A (es)
UY (1) UY27717A1 (es)
WO (1) WO2003076429A2 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2601964B1 (en) * 2005-03-21 2018-07-25 The Trustees of Columbia University in the City of New York Balanol compounds for use in treating pain
WO2007095586A2 (en) 2006-02-14 2007-08-23 The Trustees Of Columbia University In The City Of New York Neuronal pain pathway modulators
WO2015011031A1 (en) * 2013-07-23 2015-01-29 F. Hoffmann-La Roche Ag Small molecule based conversion of somatic cells into neural crest cells
EP3473628B1 (en) * 2016-06-16 2019-12-11 Harbin Zhenbao Pharmaceutical Co., Ltd. Dihydropyrazole azepine compound serving as akt inhibitor
JP7329509B2 (ja) * 2017-10-31 2023-08-18 ユニバーシティ オブ マイアミ 中枢および末梢神経系障害の治療のためのキナーゼ阻害剤
CN107759606B (zh) * 2017-11-29 2018-12-21 南京诺希生物科技有限公司 具有抗肿瘤活性的氮杂环烯烃并二氮卓药物分子及其制备方法
WO2019114741A1 (zh) * 2017-12-13 2019-06-20 南京明德新药研发股份有限公司 作为Akt抑制剂的盐型及其晶型

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL86632A0 (en) 1987-06-15 1988-11-30 Ciba Geigy Ag Derivatives substituted at methyl-amino nitrogen
JPH09503994A (ja) 1993-03-03 1997-04-22 イーライ・リリー・アンド・カンパニー バラノイド
HU219709B (hu) 1993-12-07 2001-06-28 Eli Lilly And Co. Proteinkináz C gátló hatású kondenzált indolszármazékok, eljárás előállításukra, és az ezeket tartalmazó gyógyászati készítmények
AU686691B2 (en) * 1994-01-12 1998-02-12 F. Hoffmann-La Roche Ag Novel azepanes and homologs thereof
US5583221A (en) 1994-05-04 1996-12-10 Eli Lilly And Company Substituted fused and bridged bicyclic compounds as therapeutic agents
TW339325B (en) 1995-07-05 1998-09-01 Hoffmann La Roche Novel azepane derivatives, process for the preparation thereof and pharmaceutical composition containing the same
EP0802190A1 (de) 1996-04-17 1997-10-22 F. Hoffmann-La Roche Ag Verfahren zur Herstellung von Azepinen
JP2000186092A (ja) 1998-12-22 2000-07-04 Kyowa Hakko Kogyo Co Ltd Ｕｃｎ−０１の製造法

Also Published As

Publication number Publication date
AU2003218715A8 (en) 2003-09-22
EP1487819A2 (en) 2004-12-22
UY27717A1 (es) 2003-09-30
CA2478276A1 (en) 2003-09-18
WO2003076429A2 (en) 2003-09-18
CN1639151A (zh) 2005-07-13
US6887864B2 (en) 2005-05-03
TW200401644A (en) 2004-02-01
WO2003076429A3 (en) 2004-01-08
AR038916A1 (es) 2005-02-02
CN1321116C (zh) 2007-06-13
US20030181716A1 (en) 2003-09-25
JP2005524671A (ja) 2005-08-18
AU2003218715A1 (en) 2003-09-22
PE20040205A1 (es) 2004-04-08

Similar Documents

Publication Publication Date Title
CR8266A (es) Derivados de pirimidina para el tratamiento del crecimiento celular anormal
BRPI0512988A (pt) método para aumentar a meia-vida plasmática de uma molécula, composto, uso do mesmo, e, composição farmacêutica
UY28572A1 (es) Compuestos novedosos
CR8357A (es) Derivados de tetrahidronaftaleno, procedimiento para su preparacion y su uso como antiinflamatorio
PA8541601A1 (es) Derivados espirociclicos nuevos y su uso como inhibidores de fosfodiesterasa-7.
ECSP055899A (es) Pirimidinas inhibidoras de chk, pdk y akt, su producción y su uso como agentes farmacéuticos
ECSP066717A (es) Compuestos de quinolina sustituidos
ECSP088367A (es) Derivados de bifenilo y su uso en el tratamiento de la hepatitis c
UY28014A1 (es) Compuestos quimicos
UY27571A1 (es) 2-tio-3, 5-diciano-4-fenil-6-aminopiridinas sustituidas y su uso
HN2004000544A (es) Nuevos derivados de quinolinas
DOP2002000433A (es) 2-tio-3,5-diciano-4-fenil-6-aminopiridinas substituidas y su uso
ECSP099413A (es) COMPUESTOS A BASE DE 4 - fenil - 6 - (2,2,2 - trifluoro - 1 - feniletoxi)pirimidina Y MÉTODOS PARA SU EMPLEO
ECSP045004A (es) Inhibidores de la 17beta-hidroxiesteroide deshidrogenasa tipo 3 para el tratamiento de enfermedades andrógeno dependientes
PA8680701A1 (es) Derivados de oxindol
ECSP066643A (es) PIRIDO [2,3-d] PIRIMIDINA-2,4-DIAMINAS COMO INHIBIDORES DE PDE 2
ECSP066540A (es) Pentanoles transpuestos, un método para prepararlos y su uso como antiinflamatorios
ECSP077302A (es) 6H-[1]BENZOPIRANO[4,3-b]QUlNOLINAS, Y SU USO COMO AGENTES ESTROGENICOS
HN2003000422A (es) Derivados de pirimidina para el tratamiento del crecimiento celular anormal.
CR11518A (es) Compuestos de carbamoilo como inhibidores de dgat1 190
ECSP066972A (es) Profármacos mutuos de glucosamina y glucosamina/anti-inflamatorio, composiciones, y métodos
DK1638928T3 (da) N-alkynyl-2-(substituerede aryloxy)alkylthio-amidderivater som fungicider
UY29213A1 (es) Derivados de quinolina e isoquinolina 5-sustitiuidos, un procedimiento para su preparación y su uso como inhibidores de la inflamación
ECSP088156A (es) Compuestos farmacéuticos novedosos
PA8577201A1 (es) 3-fenil-propionamido, 3-fenil-acrilamido y derivados 3-fenil-propinamido como inhibidores de mao-b